Cargando…
Fecal short chain fatty acids and urinary 3-indoxyl sulfate do not discriminate between patients with Crohn´s disease and ulcerative colitis and are not of diagnostic utility for predicting disease severity
BACKGROUND: Urinary 3-indoxyl sulfate levels as well as fecal short chain fatty acid (SCFA) concentrations are surrogate markers for gut microbiota diversity. Patients with inflammatory bowel diseases (IBDs) and patients with primary sclerosing cholangitis (PSC), a disease closely associated with IB...
Autores principales: | Tews, Hauke Christian, Elger, Tanja, Gunawan, Stefan, Fererberger, Tanja, Sommersberger, Stefanie, Loibl, Johanna, Huss, Muriel, Liebisch, Gerhard, Müller, Martina, Kandulski, Arne, Buechler, Christa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546683/ https://www.ncbi.nlm.nih.gov/pubmed/37789460 http://dx.doi.org/10.1186/s12944-023-01929-6 |
Ejemplares similares
-
Altered fecal bile acid composition in active ulcerative colitis
por: Sommersberger, Stefanie, et al.
Publicado: (2023) -
Urinary chemerin as a potential biomarker for inflammatory bowel disease
por: Gunawan, Stefan, et al.
Publicado: (2022) -
Fecal and Urinary Adipokines as Disease Biomarkers
por: Tews, Hauke C., et al.
Publicado: (2023) -
The fecal microbiome and serum concentrations of indoxyl sulfate and p‐cresol sulfate in cats with chronic kidney disease
por: Summers, Stacie C., et al.
Publicado: (2018) -
Preliminary evaluation of fecal fatty acid concentrations in cats with chronic kidney disease and correlation with indoxyl sulfate and p‐cresol sulfate
por: Summers, Stacie, et al.
Publicado: (2019)